Zepp Health Corporation
ZEPP
$8.62
-$0.38-4.22%
NYSE
| 12/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 182.65M | 206.12M | 246.77M | 298.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 182.65M | 206.12M | 246.77M | 298.58M |
| Cost of Revenue | -- | 112.40M | 128.96M | 158.68M | 206.53M |
| Gross Profit | -- | 70.25M | 77.16M | 88.08M | 92.05M |
| SG&A Expenses | -- | 71.31M | 68.58M | 66.09M | 68.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 229.84M | 243.74M | 270.47M | 322.80M |
| Operating Income | -- | -47.18M | -37.62M | -23.70M | -24.22M |
| Income Before Tax | -- | -62.04M | -37.21M | -23.62M | -24.54M |
| Income Tax Expenses | -- | 13.69M | 2.89M | 2.96M | 1.26M |
| Earnings from Continuing Operations | -- | -75.74 | -40.10 | -26.58 | -25.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 75.20K | 35.20K | 54.20K | 70.20K |
| Net Income | -- | -75.66M | -40.07M | -26.52M | -25.72M |
| EBIT | -- | -47.18M | -37.62M | -23.70M | -24.22M |
| EBITDA | -- | -40.17M | -29.94M | -15.95M | -16.38M |
| EPS Basic | -- | -74.98 | -39.64 | -26.20 | -26.10 |
| Normalized Basic EPS | -- | -1.68 | -1.06 | -0.53 | -0.53 |
| EPS Diluted | -- | -75.10 | -40.91 | -27.53 | -27.43 |
| Normalized Diluted EPS | -- | -1.68 | -1.06 | -0.53 | -0.53 |
| Average Basic Shares Outstanding | -- | 64.72M | 63.74M | 62.79M | 61.73M |
| Average Diluted Shares Outstanding | -- | 4.04M | 3.98M | 3.97M | 3.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |